Ransh Pharma Pvt. Ltd was founded in 2018 as a medium-scale industry initially focused on a select range of products, with a capacity of 140KL along with a pilot plant. We are strategically planning to expand our manufacturing capabilities to 240KL by the year 2024, incorporating a state-of-the-art Clean Room Facility dedicated to the production of Active Pharmaceutical Ingredients (APIs).

We are dedicated to the production of Key Starting Materials (KSMs), Intermediates, and Specialty Chemicals, ensuring compliance with stringent quality standards for both domestic and international clientele.
Our commitment extends to operating within a secure and health-conscious environment. Our versatile infrastructure is purposefully designed to accommodate the intricacies of executing complex and potentially hazardous chemical processes with a focus on safety and efficiency.
Our highly skilled personnel possess expertise in handling diverse process chemistries. The plant has undergone successful audits by various regulatory authorities and companies, affirming its adherence to the quality system guidelines advocated by the ICH Q7 standard.

Manufacturing Facility

Currently running at 140 KL along with a pilot plant, we take pride in possessing sophisticated and high-end equipment in par and beyond those among our competitors of similar scale.

• Hydrogenator
• High Vacuum Distillation (HVD)
• Cryogenic Reactor
• GL ANFD

Our plant is located in Gurajapalem (V), Rambilli (M), Atchutapuram, Anakapalle District, Andhra Pradesh, India, with the postal code 531 061.

Management

The Board of Directors at Ransh Pharma Pvt. Ltd. is composed of eminent individuals with expertise spanning various fields. Operating with autonomy and independence, the board exercises strategic oversight, fulfills fiduciary duties, and ensures that the management adheres to the highest standards of ethics, transparency, and disclosure.

Our Team

Mr. C.P. Rao Chitakana

Managing Director

Mr. Chitakana is a first-generation entrepreneur in the pharmaceutical industry. As a results-driven and strategic director, he has consistently demonstrated his proficiency in developing and fortifying management teams to optimize efficiency at Ransh Pharma Pvt. Ltd. The ongoing mission is steadfastly guided by his philosophy of harmonizing economic growth with social responsibility. His visionary leadership and unwavering commitment serve as the primary driving force propelling the company forward.

Dr. Radhakrishna Tatini

Director

Mr. Tatini is a Ph.D from Andhra University and Post-doctoral research from State University of New York, Binghamton USA. He is an accomplished scientist and leader with a broad range of expertise in development of pharmaceutical drug products from project initiation to commercialization and life cycle management. He has over Twenty-eight years of professional experience in development of variety of dosage forms including Topical Semi-Solids and Liquids; Nasal spray; Oral Liquids and Solids; Sterile Ophthalmic, Otic and Injectable and Active Pharmaceutical Ingredients. His experience spans across areas of analytical research, product development, regulatory submission, technology transfer, quality and regulatory compliance. Dr. Radhakrishna worked in several pharmaceutical companies both in the USA and India. Most recently, he served as Executive Director – R&D for Akorn Pharma. Before moving to the USA, he spent over six years in the discovery and development of New Chemical Entities (NCEs) at Dr. Reddy’s Discovery Research Foundation, India. He Published several Research Papers in highly rated Scientific Journals.

Mr. Venkata Ramana Veligatla

Director

Mr. Veligatla is a science graduate in Chemistry from Nagarjuna University, bringing with him over twenty-five years of professional expertise in Plant Operations, Product Analysis, and Product Costing. Prior to joining Ransh Pharma Pvt. Ltd., he served as the Plant Head at Shree Jaya Laboratories, Hetero, and held significant roles at esteemed organizations such as Laurus Labs, Aurobindo Pharma, and Wanbury.

Mr. Srinivasa Rao Putta

Director

Mr. Putta is a science graduate in Analytical Chemistry from Andhra University, bringing to the role over twenty-five years of professional expertise encompassing Quality, Regulatory Compliance, Business Development, Supply Chain, Procurement, Marketing and Sales, as well as Statutory and Liaisoning activities. In his notable professional trajectory prior to joining Ransh Pharma Pvt. Ltd, Mr. Putta held key positions at MyOSynth, Glochem, Aurobindo Pharma, Granules India, and Neuland Laboratories.

Our Vision

To enhance our manufacturing capabilities through a steadfast commitment to quality, aspiring to become a premier manufacturer of Key Starting Materials (KSMs), Intermediates, Specialty Chemicals, and Active Pharmaceutical Ingredients (APIs) with a diversified portfolio, positioning ourselves as a prominent player in the global pharmaceutical industry.

Our Mission

To act as a responsible corporate entity, dedicated to serving the broader community by engaging in business, social, and environmental initiatives that actively contribute to a more sustainable and promising future.

Our Values

We endorse the belief that unity with unwavering commitment, passion, and accountability serves as the foundational pillars for a promising tomorrow.

Accredations & Certifications